Martin & Co. Inc. TN bought a new position in shares of Hawkins, Inc. (NASDAQ:HWKN – Free Report) in the second quarter, according to the company in its most recent filing with the SEC. The fund bought 24,629 shares of the specialty chemicals company’s stock, valued at approximately $3,500,000.
A number of other institutional investors and hedge funds have also recently bought and sold shares of HWKN. De Lisle Partners LLP acquired a new stake in Hawkins during the 2nd quarter worth approximately $11,660,000. William Blair Investment Management LLC acquired a new position in Hawkins during the second quarter valued at approximately $27,212,000. Callan Family Office LLC acquired a new position in Hawkins during the second quarter valued at approximately $2,713,000. B. Metzler seel. Sohn & Co. AG purchased a new stake in Hawkins during the second quarter worth approximately $1,356,000. Finally, NewEdge Wealth LLC purchased a new stake in Hawkins during the second quarter worth approximately $1,389,000. Institutional investors and hedge funds own 69.71% of the company’s stock.
Analyst Ratings Changes
Several equities research analysts have recently issued reports on HWKN shares. Zacks Research lowered shares of Hawkins from a “hold” rating to a “strong sell” rating in a research report on Tuesday, August 4th. Barclays set a $142.00 price target on shares of Hawkins and gave the stock an “equal weight” rating in a research report on Friday, July 31st. Weiss Ratings downgraded Hawkins from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, July 14th. Finally, BWS Financial reissued a “buy” rating and issued a $200.00 price objective on shares of Hawkins in a research report on Monday, August 3rd. One investment analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $171.00.
Hawkins Stock Performance
Hawkins stock opened at $118.99 on Friday. The firm has a market capitalization of $2.48 billion, a PE ratio of 30.83, a price-to-earnings-growth ratio of 2.45 and a beta of 0.79. Hawkins, Inc. has a one year low of $117.98 and a one year high of $186.15. The stock’s 50 day moving average price is $140.27 and its 200 day moving average price is $147.56. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.54 and a current ratio of 2.27.
Hawkins (NASDAQ:HWKN – Get Free Report) last issued its quarterly earnings data on Wednesday, July 29th. The specialty chemicals company reported $1.35 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.39 by ($0.04). The firm had revenue of $315.68 million during the quarter, compared to analyst estimates of $313.42 million. Hawkins had a net margin of 7.29% and a return on equity of 15.42%. As a group, sell-side analysts expect that Hawkins, Inc. will post 4.04 EPS for the current fiscal year.
Hawkins Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, August 28th. Stockholders of record on Friday, August 14th will be paid a $0.19 dividend. The ex-dividend date is Friday, August 14th. This represents a $0.76 annualized dividend and a dividend yield of 0.6%. Hawkins’s dividend payout ratio is 20.73%.
Hawkins Company Profile
Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.
Hawkins’ product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.
Featured Articles
- Five stocks we like better than Hawkins
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Want to see what other hedge funds are holding HWKN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hawkins, Inc. (NASDAQ:HWKN – Free Report).
Receive News & Ratings for Hawkins Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hawkins and related companies with MarketBeat.com's FREE daily email newsletter.
